Financial reports
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
27 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
28 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
10-Q
2021 Q2
Quarterly report
12 Aug 21
Current reports
8-K
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
1 Dec 23
8-K
Entry into a Material Definitive Agreement
16 Nov 23
8-K
Departure of Directors or Certain Officers
8 Aug 23
8-K
Departure of Directors or Certain Officers
28 Jul 23
8-K
Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps Down
13 Jul 23
8-K
Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain Assets
6 Jul 23
8-K
Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone Payment
16 Jun 23
8-K
Navidea Biopharmaceuticals, Inc. Announces Distribution of Series K Preferred Stock to Holders of its Common Stock
16 Jun 23
8-K
Entry into a Material Definitive Agreement
2 Jun 23
8-K
Entry into a Material Definitive Agreement
25 May 23
Registration and prospectus
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Jan 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Jan 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Jan 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Jan 24
POS AM
Prospectus update (post-effective amendment)
26 Jan 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Jan 24
POS AM
Prospectus update (post-effective amendment)
26 Jan 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Jan 24
POS AM
Prospectus update (post-effective amendment)
26 Jan 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Jan 24
Proxies
DEFA14A
Additional proxy soliciting materials
13 Nov 23
DEF 14A
Definitive proxy
5 Oct 23
PRE 14A
Preliminary proxy
15 Sep 23
DEF 14A
Definitive proxy
3 Jul 23
PRE 14A
Preliminary proxy
16 Jun 23
DEF 14A
Definitive proxy
24 Oct 22
PRE 14A
Preliminary proxy
13 Oct 22
DEF 14A
Definitive proxy
2 Aug 21
DEF 14A
Definitive proxy
31 Jul 20
DEFA14A
Additional proxy soliciting materials
28 Jun 19
Other
EFFECT
Notice of effectiveness
1 Feb 24
EFFECT
Notice of effectiveness
1 Feb 24
EFFECT
Notice of effectiveness
1 Feb 24
EFFECT
Notice of effectiveness
1 Feb 24
EFFECT
Notice of effectiveness
1 Feb 24
EFFECT
Notice of effectiveness
11 Sep 23
CORRESP
Correspondence with SEC
7 Sep 23
UPLOAD
Letter from SEC
5 Sep 23
SD
Conflict minerals disclosure
1 Jun 23
EFFECT
Notice of effectiveness
4 Aug 22